Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of CTL0901 and CTL0902 in Healthy Volunteers
NCT05009368Phase 1Completed
- Sponsor
- Celltrion
- Start
- Jul 2021
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of azilsartan medoxomil, rosuvastatin and ezetimibe in hypertension (HTN) and hyperlipidemia (2 arms), sponsored by Celltrion. Primary endpoints: Area Under the Concentration-Time Curve at Steady State over Dosing Interval and Maximum Plasma Concentration at Steady State. Started Jul 2021; status: completed.
02
Drugs
azilsartan medoxomilrosuvastatinezetimibe
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT05009368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05009368.